Is Livongo-Teladoc merger a ‘leap forward’ for digital health?
pharmaphorum
AUGUST 18, 2020
Teladoc is the only public-traded telehealth company in the US, and concerns from its investors seemed to centre on the price it was paying to meld with Livongo , particularly as the value of the latter’s stock sank below the offer price soon after it was announced. Its second-quarter revenue leaped 125% to almost $92 million.
76 
Let's personalize your content